**Equity Swap Contract**

This contract is an equity swap agreement between two parties, Party A and Party B, entered into on January 19, 2009. The trade identifier for this contract is 1147071, issued by Party A and Party B.

**General Terms**

* Trade Date: January 19, 2009
* Effective Date: January 19, 2009
* Termination Date: March 19, 2009
* Mandatory Early Termination: Applicable
* Mandatory Early Termination Date: November 3, 2009
* Notional Amount: EUR 10,000,000
* Business Day Convention: Following
* Calculation Agent: Party A (unless stated otherwise in ISDA)
* Governing Law: English
* Documentation: ISDA

**Party A Payments**

* Party A pays (in EUR): 4.427% p.a. on the Notional Amount
* Party A Calculation Period: From and including the Effective Date to, but excluding, the Termination Date
* Party A Payment Dates: Annually 2 Business Days after the Effective Date, commencing on January 21, 2009, up to and including March 23, 2009
* Party A Day Count: ACT/360

**Party B Payments**

* Party B pays (in EUR): EUR SOFR-COMPOUND p.a. on the Notional Amount
* Party B Calculation Period: From and including the Effective Date to, but excluding, the Termination Date
* Party B Payment Dates: Annually 2 Business Days after the Effective Date, commencing on January 21, 2009, up to and including March 23, 2009
* Party B Day Count: ACT/360

**Mandatory Early Termination Clause**

This swap shall be terminated on the Mandatory Early Termination Date at the market value of the swap, as on the Mandatory Early Termination Date, subject to adjustment in accordance with the Modified Following Business Day Convention.

**Risk Disclosure**

There are significant risks associated with this Transaction, including, but not limited to, foreign exchange risk, price risk, liquidity risk, and credit risk. Counterparties should consult their own financial, legal, accounting, and tax advisors about the risks associated with this Transaction.

**Underlying Exposure**

This Transaction has been entered into to hedge the risk arising out of the underlying exposure, which is a USD 10,000,000 fixed rate loan, maturing on or after October 5, 2033.

**Purpose of the Transaction**

The purpose of the equity swap transaction is to convert the fixed rate USD liability of Party B into a floating rate liability with the view that future interest rates will be lower than currently projected.

**Scenario Analysis**

The following Scenario Analysis is provided for illustrative and convenience purposes only. It should not be relied on by Party B, and Party A expressly disclaims any responsibility or reliance by Party B.

Scenario 1: EUR SOFR-COMPOUND remains unchanged over the tenor of the trade; EUR Overnight SOFR Curve remains unchanged till the Mandatory Termination Date.

Scenario 2: EUR SOFR-COMPOUND increases over the tenor of the trade; EUR Overnight SOFR Curve is 10bps higher on the Mandatory Termination Date as compared to that on Trade Date.

Scenario 3: EUR SOFR-COMPOUND decreases over the tenor of the trade; EUR Overnight SOFR Curve is 10bps lower on the Mandatory Termination Date as compared to that on Trade Date.

**Mark to Market (MTM) Sensitivity Analysis**

The following MTM Analysis is provided for illustrative and convenience purposes only. It should not be relied on by Party B, and Party A expressly disclaims any responsibility or reliance by Party B.

MTM Sensitivity due to parallel shift in EUR SOFR-COMPOUND Curve immediately after Trade Date:

Parallel Shift in EUR SOFR-COMPOUND Curve Changes in the MTM (in EUR)

500 bps up -3,969,875
100 bps up -796,597
50 bps up -398,415
10 bps up -79,698
0 0
10 bps down 79,712

MTM Sensitivity due to parallel shift in EUR SOFR-COMPOUND Curve as on Mandatory Termination Date compared to Trade Date:

Parallel Shift in EUR SOFR-COMPOUND Curve Changes in the MTM (in EUR)

500 bps up -3,955,433
100 bps up -800,160
50 bps up -404,181
10 bps up -87,221
0 -7,962
10 bps down 71,311

**Level of Pricing Variables and Impact of Variables on Pricing**

The following analysis is provided for information and illustrative purposes only. All information provided herein is indicative, non-exhaustive, and is based on certain assumptions and current market conditions and is subject to change without notice.

The market level of primary market variables used in determining the price of the transaction is as follows:

EUR 10 year SOFR-COMPOUND Rate: 4.427%

The primary market variables used for determining the mark-to-market value along with their directional impact are listed below for information purposes only and is subject to change.

**Representations**

Each party represents to the other party on the date on which it enters into this Transaction that (absent a written agreement between the parties in respect of this Transaction that expressly imposes affirmative obligations to the contrary):

(i) It is acting for its own account, and it has made its own independent decisions to enter into this Transaction and as to whether this Transaction is appropriate or proper for it based upon its own judgment and upon advice from such tax, accounting, regulatory, legal, and financial advisers as it has deemed necessary, and not upon any view expressed by the other.

(ii) It is capable of assessing the merits of and understanding (on its own behalf or through independent professional advice), and understands and accepts, the terms, conditions, and risks of this Transaction. It is also capable of assuming, and assumes, the risks of this Transaction.

(iii) The other party is not acting as a fiduciary for, or an adviser to it in respect of this Transaction.

(iv) This Transaction is subject at all times, to the applicable laws, including but not limited to the Reserve Bank of India (“RBI”) and the Foreign Exchange Management Act, 1999, rules, regulations, and guidelines issued thereunder, as may be amended from time to time (collectively, the “Regulations”) and does not contravene any of the said Regulations.

**Counterparty Representations**

With respect to this Transaction, Party B represents and confirms to Party A as follows:

1. It has the power to enter into this Transaction and to deliver any document relating to this Transaction and to perform its obligations under this Transaction and has taken all necessary action to authorize such execution, delivery, and performance.

2. All necessary governmental and other consents that are required to have been obtained by it with respect to this Transaction (or any part thereof) have been obtained and are in full force and effect and all conditions of any such consents have been (and shall continue to be) complied with.

3. Its entry into and performance of its obligations under this Transaction does not and will not result in a breach or violation of any applicable law or regulation.

4. That it is entering into this Transaction solely for the purpose of hedging its underlying exposure (“Underlying Exposure”) and not for purposes of speculation, and the size and tenure of this Transaction is not in excess of Party B’s Underlying Exposure.

5. This Transaction has been booked against the said Underlying Exposure and the Underlying Documents in respect of the said Underlying Exposure have been/ will be provided to Party A by Party B.

6. It has familiarized itself and fully understood the above terms and conditions and accepts the risks of entering into this Transaction.